The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Blood-brain barrier disruption in multiple sclerosis
Abstract
The blood-brain barrier (BBB) is a complex organization of cerebral endothelial cells (C EC), pericytes and their basal lamina, which are surrounded and supported by astrocytes and perivascular macrophages. C ollectively these cells separate and form the compartments of the cerebral vascular space and the cerebral interstitium under normal conditions. Without the BBB, the ‘interior milieu’ of the central nervous system (CNS) would be flooded by humoral neurotransmitters and formed blood elements that upset normal C NS functions and lead to vascular/neural injury. Dysregulation of the BBB and transendo thelial migration of activated leukocytes are among the earliest cerebrovascular abnormalities seen in multiple sclerosis (MS) brains and parallel the release of inflammatory cytokines/chemokines. Mechanisms for breakdown of the BBB in MS are incompletely understood, but appear to involve direct effects of these cytokines/chemokines on endothelial regulation of BBB components, as well as indirect cytokine/chemokine-dependent leukocyte mediated injury. Unique endothelial structural features of the BBB include highly organized endothelial tight junctions, the absence of class II major histocompatibility complex, abundant mitochondria and a highly developed transport system in C EC. Exposure of endothelium to proinflammatory cytokines (IFN-g, TNF-a and IL-1b) interrupts the BBB by disorganizing cell-cell junctions, decreases the brain solute barrier, enhances leukocyte endothelial adhesion and migration as well as increases expression of class II MHC and promotes shedding of endothelial ‘microparticles’ (EMP). In this review we examine interactions between cytokines/chemokines, activated leukocytes, adhesion molecules and activated C EC in the pathogenesis of BBB failure in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,630
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Occludin: a novel integral membrane protein localizing at tight junctions.
Furuse, M., Hirase, T., Itoh, M., Nagafuchi, A., Yonemura, S., Tsukita, S., & Tsukita, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.123.6.1777 · Cited by 2,580
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Jonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Martìn-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C., Stoppacciaro, A., Ruco, L., Villa, A., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.1.117 · Cited by 1,388
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Miller, D. H., Khan, O. A., Sheremata, W. A., Blumhardt, L. D., Rice, G. P. A., Libonati, M. A., Willmer-Hulme, A. J., Dalton, C. M., Miszkiel, K. A., & O'Connor, P. W. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020696 · Cited by 1,242
Tight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Astrocyte-endothelial Interactions and Blood-Brain Barrier Permeability*
Abbott, N. J. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00064.x · Cited by 1,168
Itoh, M., Furuse, M., Morita, K., Kubota, K., Saitou, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.6.1351 · Cited by 1,151
Griendling, K. K., Sorescu, D., Lassègue, B., & Ushio-Fukai, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J.-M., & Tedgui, A. (2000) · Circulation · doi:10.1161/01.cir.101.8.841 · Cited by 883
Morita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869
Combes, V., Simon, A.-C., Grau, G.-E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., & Dignat-George, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4985 · Cited by 732
Chemokines, leukocyte trafficking, and inflammation
Schall, T. J., & Bacon, K. B. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90006-x · Cited by 615
KERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578
The role of nitric oxide in multiple sclerosis
Smith, K. J., & Lassmann, H. (2002) · The Lancet Neurology · doi:10.1016/s1474-4422(02)00102-3 · Cited by 531
Brück, W., Bitsch, A., Kolenda, H., Brück, Y., Stiefel, M., & Lassmann, H. (1997) · Annals of Neurology · doi:10.1002/ana.410420515 · Cited by 519
T cell gelatinases mediate basement membrane transmigration in vitro.
Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W., & Hauser, S. L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4379 · Cited by 492
Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Acta Neuropathologica · doi:10.1007/s004010000180 · Cited by 491
The Blood-Brain Barrier in Neuroinflammatory Diseases
de Vries, H. E., Kuiper, J., de Boer, A. G., Van Berkel, T. J. C., & Breimer, D. D. (1997) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01320-6 · Cited by 429
Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodroofe, M. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00208-7 · Cited by 408
Patterns of oligodendroglia pathology in multiple sclerosis
Ozawa, K., Suchanek, G., Breitschopf, H., Br€ck, W., Budka, H., Jellinger, K., & Lassmann, H. (1994) · Brain · doi:10.1093/brain/117.6.1311 · Cited by 404
Mechanisms of the Antioxidant Effects of Nitric Oxide
Wink, D. A., Miranda, K. M., Espey, M. G., Pluta, R. M., Hewett, S. J., Colton, C., Vitek, M., Feelisch, M., & Grisham, M. B. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601300185179 · Cited by 400
RAO, R. K., BASUROY, S., RAO, V. U., KARNAKY, K. J., & GUPTA, A. (2002) · Biochemical Journal · doi:10.1042/bj20011804 · Cited by 399
Hooper, D. C., Scott, G. S., Zborek, A., Mikheeva, T., Kean, R. B., Koprowski, H., & Spitsin, S. V. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.5.691 · Cited by 390
Katz, D., Taubenberger, J. K., Cannella, B., McFarlin, D. E., Raine, C. S., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410340507 · Cited by 387
McManus, C., Berman, J. W., Brett, F. M., Staunton, H., Farrell, M., & Brosnan, C. F. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00002-2 · Cited by 380
Bolton, S. J., Anthony, D. C., & Perry, V. H. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00058-x · Cited by 369
McFarland, H. F., Frank, J. A., Albert, P. S., Smith, M. E., Martin, R., Harris, J. O., Patronas, N., Maloni, H., & McFarlin, D. E. (1992) · Annals of Neurology · doi:10.1002/ana.410320609 · Cited by 346
Ando-Akatsuka, Y., Saitou, M., Hirase, T., Kishi, M., Sakakibara, A., Itoh, M., Yonemura, S., Furuse, M., & Tsukita, S. (1996) · The Journal of cell biology · doi:10.1083/jcb.133.1.43 · Cited by 331
Kevil, C. G., Payne, D. K., Mire, E., & Alexander, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15099 · Cited by 320
Self-citationHirase, T., Kawashima, S., Wong, E. Y. M., Ueyama, T., Rikitake, Y., Tsukita, S., Yokoyama, M., & Staddon, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007136200 · Cited by 311
Structural and signalling molecules come together at tight junctions
Tsukita, S., Furuse, M., & Itoh, M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00016-2 · Cited by 305
Transmembrane proteins in the tight junction barrier
FANNING, A. S., MITIC, L. L., & ANDERSON, J. M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061337 · Cited by 301
Maeda, A., & Sobel, R. A. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00005 · Cited by 291
Elevated plasma endothelial microparticles in multiple sclerosis
Minagar, A., Jy, W., Jimenez, J. J., Sheremata, W. A., Mauro, L. M., Mao, W. W., Horstman, L. L., & Ahn, Y. S. (2001) · Neurology · doi:10.1212/wnl.56.10.1319 · Cited by 289
Self-citationMultiple sclerosis: gadolinium enhancement in MR imaging.
Grossman, R. I., Gonzalez-Scarano, F., Atlas, S. W., Galetta, S., & Silberberg, D. H. (1986) · Radiology · doi:10.1148/radiology.161.3.3786722 · Cited by 289
Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ
Mankertz, J., Tavalali, S., Schmitz, H., Mankertz, A., Riecken, E. O., Fromm, M., & Schulzke, J. D. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.2085 · Cited by 287
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
Rosenberg, G. A., Kornfeld, M., Estrada, E., Kelley, R. O., Liotta, L. A., & Stetler-Stevenson, W. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90681-x · Cited by 281
Nesbit, G. M., Forbes, G. S., Scheithauer, B. W., Okazaki, H., & Rodriguez, M. (1991) · Radiology · doi:10.1148/radiology.180.2.2068314 · Cited by 275
JAM-2, a Novel Immunoglobulin Superfamily Molecule, Expressed by Endothelial and Lymphatic Cells
Aurrand-Lions, M., Duncan, L., Ballestrem, C., & Imhof, B. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005458200 · Cited by 248
Smith, M. E., Stone, L. A., Albert, P. S., Frank, J. A., Martin, R., Armstrong, M., Maloni, H., McFarlin, D. E., & McFarland, H. F. (1993) · Annals of Neurology · doi:10.1002/ana.410330511 · Cited by 241
Mechanisms of Immune Injury in Multiple Sclerosis
Brosnan, C. F., & Raine, C. S. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00853.x · Cited by 240
Palmeri, D., van Zante, A., Huang, C.-C., Hemmerich, S., & Rosen, S. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003189200 · Cited by 235
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis
Waubant, E., Goodkin, D. E., Gee, L., Bacchetti, P., Sloan, R., Stewart, T., Andersson, P.-B., Stabler, G., & Miller, K. (1999) · Neurology · doi:10.1212/wnl.53.7.1397 · Cited by 234
Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis
Rieckmann, P., Albrecht, M., Kitze, B., Weber, T., Tumani, H., Broocks, A., Lüer, W., & Poser, S. (1994) · Neurology · doi:10.1212/wnl.44.8.1523 · Cited by 225
Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins
Carden, D., Xiao, F., Moak, C., Willis, B. H., Robinson-Jackson, S., & Alexander, S. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.2.h385 · Cited by 222
Liebner, S., Kniesel, U., Kalbacher, H., & Wolburg, H. (2000) · European Journal of Cell Biology · doi:10.1078/0171-9335-00101 · Cited by 203
Allport, J. R., Muller, W. A., & Luscinskas, F. W. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.1.203 · Cited by 199
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis
Lee, M. A., Palace, J., Stabler, G., Ford, J., Gearing, A., & Miller, K. (1999) · Brain · doi:10.1093/brain/122.2.191 · Cited by 199
Dejana, E., Spagnuolo, R., & Bazzoni, G. (2001) · PubMed · Cited by 198
Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins
Tsukamoto, T., & Nigam, S. K. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f737 · Cited by 195
Analysis of tight junctions during neutrophil transendothelial migration
Burns, A. R., Bowden, R. A., MacDonell, S. D., Walker, D. C., Odebunmi, T. O., Donnachie, E. M., Simon, S. I., Entman, M. L., & Smith, C. W. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.1.45 · Cited by 194
Oshima, T., Laroux, F. S., Coe, L. L., Morise, Z., Kawachi, S., Bauer, P., Grisham, M. B., Specian, R. D., Carter, P., Jennings, S., et al. (2001) · Microvascular Research · doi:10.1006/mvre.2000.2288 · Cited by 190
Self-citationProescholdt, M. A., Jacobson, S., Tresser, N., Oldfield, E. H., & Merrill, M. J. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.10.914 · Cited by 182
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions
Cossins, J. A., Clements, J. M., Ford, J., Miller, K. M., Pigott, R., Vos, W., Van Der Valk, P., & De Groot, C. J. A. (1997) · Acta Neuropathologica · doi:10.1007/s004010050754 · Cited by 176
Hartung, H., Reiners, K., Archelos, J. J., MICHELS, M., Seeldrayers, P., Heidenreich, F., Pflughaupt, K. W., & Toyka, K. V. (1995) · Annals of Neurology · doi:10.1002/ana.410380210 · Cited by 174
Matrix metalloproteinases in inflammatory demyelination: Targets for treatment
Kieseier, B. C., Seifert, T., Giovannoni, G., & Hartung, H.-P. (1999) · Neurology · doi:10.1212/wnl.53.1.20 · Cited by 167
Cytokines in CNS disorders: neurotoxicity versus neuroprotection
Stoll, G., Jander, S., & Schroeter, M. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_11 · Cited by 167
Spagnuolo, R., Bazzoni, G., & Dejana, E. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616228 · Cited by 164
Lippoldt, A., Kniesel, U., Liebner, S., Kalbacher, H., Kirsch, T., Wolburg, H., & Haller, H. G. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02954-1 · Cited by 149
Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS
Trojano, M., Avolio, C., Liuzzi, G. M., Ruggieri, M., Defazio, G., Liguori, M., Santacroce, M. P., Paolicelli, D., Giuliani, F., Riccio, P., et al. (1999) · Neurology · doi:10.1212/wnl.53.7.1402 · Cited by 139
VCAM-1 signals during lymphocyte migration: role of reactive oxygen species
Cook‐Mills, J. M. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00206-7 · Cited by 134
Histopathology and the blood-cerebrospinal fluid barrier in multiple sclerosis
Lassmann, H., Suchanek, G., & Ozawa, K. (1994) · Annals of Neurology · doi:10.1002/ana.410360713 · Cited by 134
CXC and CC Chemokine Receptors on Coronary and Brain Endothelia
Berger, O., Gan, X.-H., Gujuluva, C. N., Burns, A. R., Sulur, G., Stins, M. F., Way, D., Witte, M. H., Weinand, M. E., SAID, J. W., et al. (1999) · Molecular Medicine · doi:10.1007/bf03401992 · Cited by 131
Calabresi, P. A., Pelfrey, C. M., Tranquill, L. R., Maloni, H. W., & McFarland, H. F. (1997) · Neurology · doi:10.1212/wnl.49.4.1111 · Cited by 123
Marcus, J. S., Karackattu, S. L., Fleegal, M. A., & Sumners, C. (2002) · Glia · doi:10.1002/glia.10168 · Cited by 120
Boven, L. A., Montagne, L., Nottet, H. S. L. M., & Groot, C. J. A. D. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01334.x · Cited by 120
Rieckmann, P., Altenhofen, B., Riegel, A., Baudewig, J., & Felgenhauer, K. (1997) · Annals of Neurology · doi:10.1002/ana.410410307 · Cited by 118
Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch
Lawrence, D. W., Comerford, K. M., & Colgan, S. P. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00288.2001 · Cited by 115
Trebst, C., & Ransohoff, R. M. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1975 · Cited by 115
IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS
Waubant, E. L., Goodkin, D., Bostrom, A., Bacchetti, P., Hietpas, J., Lindberg, R. L. P., & Leppert, D. (2003) · Neurology · doi:10.1212/wnl.60.1.52 · Cited by 113
Baumgärtner, W., Schütz, G. J., Wiegand, J., Golenhofen, N., & Drenckhahn, D. (2003) · Journal of Cell Science · doi:10.1242/jcs.00322 · Cited by 105
Demeuse, P., Kerkhofs, A., Struys-Ponsar, C., Knoops, B., Remacle, C., & de Aguilar, P. V. D. B. (2002) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(02)00225-x · Cited by 97
Nwariaku, F. E., Chang, J., Zhu, X., Liu, Z., Duffy, S. L., Halaihel, N., Terada, L. S., & Turnage, R. H. (2002) · Shock · doi:10.1097/00024382-200207000-00015 · Cited by 93
Longitudinal study of soluble adhesion molecules in multiple sclerosis
Giovannoni, G., Lai, M., Thorpe, J. E., et al. (1997) · Neurology · doi:10.1212/wnl.48.6.1557 · Cited by 92
The Pathological and Clinical Dynamics of Multiple Sclerosis
McDonald, W. I. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199407000-00003 · Cited by 90
The Role of p38 MAP Kinase in Hydrogen Peroxide Mediated Endothelial Solute Permeability
Kevil, C. G., Oshima, T., & Alexander, J. S. (2001) · Endothelium · doi:10.3109/10623320109165320 · Cited by 80
Self-citationH2O2-mediated permeability II: importance of tyrosine phosphatase and kinase activity
Kevil, C. G., Okayama, N., & Alexander, J. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.281.6.c1940 · Cited by 80
Self-citationInflammatory Mediators Induce Sequestration of VE-Cadherin in Cultured Human Endothelial Cells
Alexander, J. S., Alexander, B. C., Eppihimer, L. A., Goodyear, N., Haque, R., Davis, C. P., Kalogeris, T. J., Carden, D. L., Zhu, Y.-N., & Kevil, C. G. (2000) · Inflammation · doi:10.1023/a:1007025325451 · Cited by 78
Self-citationWachtel, M., Bolliger, M. F., Ishihara, H., Frei, K., Bluethmann, H., & Gloor, S. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00399.x · Cited by 76
Minagar, A., Ostanin, D. V., Long, A. C., Jennings, M. H., Kelley, R. E., Sasaki, M., & Alexander, J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms916oa · Cited by 73
Self-citationSadowski, T., & Steinmeyer, J. (2001) · Inflammation Research · doi:10.1007/s000110050742 · Cited by 72
Alexander, J. S., Jackson, S. A., Chaney, E., Kevil, C. G., & Haselton, F. R. (1998) · Inflammation · doi:10.1023/a:1022325017013 · Cited by 69
Self-citationAstrocytes and Neurons Express the Tight Junction-Specific Protein Occludin in Vitro
Bauer, H., Stelzhammer, W., Fuchs, R., Weiger, T. M., Danninger, C., Probst, G., & Krizbai, I. A. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4558 · Cited by 68
Losy, J., Niezgoda, A., & Wender, M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00092-2 · Cited by 68
Nitric Oxide Redox Species Exert Differential Permeability Effects on the Blood-Brain Barrier
Boje, K. M. K., & Lakhman, S. S. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39267-5 · Cited by 67
Petereit, H.-F., Pukrop, R., Fazekas, F., Bamborschke, S., Ropele, S., Kölmel, H. W., Merkelbach, S., Japp, G., Jongen, P. J., Hartung, H., et al. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00420-3 · Cited by 62
Methylprednisolone reduces adhesion molecules in blood and cerebrospinal fluid in patients with MS
Elovaara, I., Lällä, M., Spåre, E., Lehtimäki, T. J., & Dastidar, P. (1998) · Neurology · doi:10.1212/wnl.51.6.1703 · Cited by 59
Blasig, I. E., Mertsch, K., & Haseloff, R. F. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00180-6 · Cited by 58
Ibarra‐Alvarado, C., Galle, J., Melichar, V. O., Mameghani, A. T., & Schmidt, H. H. H. W. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.2.312 · Cited by 56
Tsukada, N., Miyagi, K., Matsuda, M., & Yanagisawa, N. (1993) · Annals of Neurology · doi:10.1002/ana.410330614 · Cited by 56
Scott, G. S., Hake, P. W., Kean, R. B., Virág, L., Szabó, C., & Hooper, D. C. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00329-0 · Cited by 54
Dore-Duffy, P., Washington, R., & Dragovic, L. (1993) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-2920-0_38 · Cited by 52
Estes, M. L., Rudick, R. A., Barnett, G. H., & Ransohoff, R. M. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530120043008 · Cited by 50
Gelati, M. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.774 · Cited by 45
High-Dose Methylprednisolone Reduces Cytokine-Induced Adhesion Molecules on Human Brain Endothelium
Gelati, M., Corsini, E., Dufour, A., Massa, G., Giombini, S., Solero, C. L., & Salmaggi, A. (2000) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100000883 · Cited by 45
Cytokines in multiple sclerosis: pro-inflammation or pro-remyelination?
Sharief, M. K. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400315 · Cited by 38
Frigerio, S., Gelati, M., Ciusani, E., Corsini, E., Dufour, A., Massa, G., & Salmaggi, A. (1998) · Journal of Neurology · doi:10.1007/s004150050275 · Cited by 35
Liebner, S., Fischmann, A., Rascher, G., Duffner, F., Grote, E.-H., Kalbacher, H., & Wolburg, H. (2000) · Cited by 34
Kamata, H., Manabe, T., Kakuta, J., Oka, S., & Hirata, H. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04675.x · Cited by 27
Astrocytes induce manganese superoxide dismutase in brain capillary endothelial cells
Schroeter, M. L., Müller, S., Lindenau, J. H., Wiesner, B., Hanisch, U., Wolf, G. L., & Blasig, I. E. (2001) · Neuroreport · doi:10.1097/00001756-200108080-00045 · Cited by 25
Matrix metalloproteinases in multiple sclerosis
Bever, C. T., & Rosenberg, G. A. (1999) · Neurology · doi:10.1212/wnl.53.7.1380 · Cited by 23
Therapeutic strategies in multiple sclerosis. I. Immunotherapy
Hohlfeldf, R. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0513 · Cited by 19
The Role of Chemokines in the Pathogenesis of Multiple Sclerosis
Woodroofe, M. N., Cross, A. K., Harkness, K. A., & Simpson, J. E. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4685-6_11 · Cited by 13
Li, Q. Q., & Bever, C. T. (2001) · Neurochemical Research · doi:10.1023/a:1011042711631 · Cited by 12
Antegren (Natalizumab)Ein viel versprechender neuer Ansatz für die Therapie der Multiplen Sklerose
Kümpfel, T., Heydari, N., & Hohlfeld, R. (2002) · Der Nervenarzt · doi:10.1007/s00115-002-1314-3 · Cited by 9
Cited by
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Metadata
- Authors
- Minagar, A., & Alexander, J. S.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2003-12
- Volume
- 9
- Issue
- 6
- Pages
- 540-549
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2155075033
- Cited by
- 638
- References
- 112
- FWCI
- 8.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.